Medical Isotope Production With Accelerator Production of Tritium (APT)

Authors

M. R. Buckner, M. Cappiello, E. Pitcher, H. O'Brien

Abstract

The Accelerator Production of Tritium (APT) Target/Blanket (T/B) facility will produce a high-energy, high-flux proton and neutron irradiation environment that is unique to the field of isotope production. In addition to converting He-3 to tritium, it can be used to create isotopes for medical applications. Although the primary mission of the APT is to create tritium for the nuclear weapons deterrent, an ancillary isotope production mission is possible without significantly impacting tritium production. Because of the unique irradiation environment, and the large volume of space available, the APT has the potential to provide a significant source of research, diagnostic, and therapeutic isotopes to the medical community.

Meeting

This abstract was presented at the 32nd Annual Midyear Meeting, "Creation and Future Legacy of Stockpile Stewardship Isotope Production, Applications, and Consumption", Tritium Enrichment and Production Session, 1/24/1999 - 1/27/1999, held in Albuquerque, NM.

 
Index of Midyear Meeting Abstracts